Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia
This is the first comprehensive exploratory economic evaluation comparing first-in-class RRMS therapies in Saudi Arabia. Findings support the adoption of MEAs and performance-based reimbursement to ensure sustainable RRMS care in resource-constrained settings.
Authors
- Hajer Almudaiheem (ORCID: https://orcid.org/0000-0002-0985-6193)
- Yaser Al Malik
- Mohamed Al Jumah
- Ahmed Al‐Jedai (ORCID: https://orcid.org/0000-0002-4730-9086)
- Rita Ojeil (ORCID: https://orcid.org/0000-0001-8078-5597)
- Fahad M. Aldosari
- Pratik Ramesh Dhopte
- Ahmed Althobaiti (ORCID: https://orcid.org/0000-0003-1664-644X)
- Faisal Al-Suweidan
- Fahad Alzureiqan
- Wejdan Abu Ras
Institutions
- Alfaisal University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Saud Medical City (SA)
- MODUL University Dubai (AE)
- Saudi Center for Organ Transplantation (SA)
- King Abdullah International Medical Research Center (SA)
- Ministry of Health (SA)
- Security Forces Hospital (SA)
- Saudi Society of Dermatology and Dermatologic Surgery (SA)
- Saudi Ophthalmological Society (SA)
- Birla Institute of Technology and Science, Pilani - Dubai Campus (AE)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fpubh.2025.1713092
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00